CurveBeam AI Limited (ASX:CVB)
Australia · Delayed Price · Currency is AUD 0.1250
-0.0050 (-3.85%)
Last updated: Sep 12, 2025, 12:48 PM AEST
CurveBeam AI Revenue
In the fiscal year ending June 30, 2025, CurveBeam AI had annual revenue of 12.10M AUD with 85.33% growth. CurveBeam AI had revenue of 7.19M in the half year ending June 30, 2025, with 22.36% growth.
Revenue
12.10M
Revenue Growth
+85.33%
P/S Ratio
4.25
Revenue / Employee
241.93K
Employees
50
Market Cap
51.40M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 12.10M | 5.57M | 85.33% |
| Jun 30, 2024 | 6.53M | -1.53M | -18.97% |
| Jun 30, 2023 | 8.06M | - | - |
| Jun 30, 2022 | - | - | - |
| Jun 30, 2021 | 795.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Pro Medicus | 212.98M |
| Cochlear | 2.34B |
| Sonic Healthcare | 9.65B |
| Ramsay Health Care | 17.79B |
| Ansell | 3.06B |
| Telix Pharmaceuticals | 1.01B |
| Mesoblast | 26.23M |